GlassScriptPhysician profile
Kelly V Betsinger
NPI 1396202685
$3,970.74
in general payments reported to CMS, 2019-2025
21 companies · $1,620 in 2025
The $1,620 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $276 · 2022: $287 · 2023: $358 · 2024: $1,430 · 2025: $1,620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,407.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $616.59 | 2021-2025 | |
| Abiomed | $386.34 | 2023-2025 | Impella |
| Acadia Pharmaceuticals INC | $333.23 | 2024-2025 | Daybue, Nuplazid |
| Inspire Medical Systems, INC. | $299.84 | 2024 | Inspire |
| Boston Scientific Corporation | $285.03 | 2025 | Ams 700, Watchman Flx |
| Kyowa Kirin, INC. | $245.55 | 2024-2025 | Crysvita |
| Neurocrine Biosciences, INC. | $237.12 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $137.86 | 2024 | Spravato |
| Abbott Laboratories | $136.26 | 2025 | Freestyle Libre 3 |
| Alkermes, INC. | $130.00 | 2025 | Lybalvi |
| Madrigal Pharmaceuticals | $127.72 | 2024 | Rezdiffra |
| Sumitomo Pharma America, INC. | $124.99 | 2023 | Gemtesa |
| Amgen INC. | $124.99 | 2024 | |
| Radius Health, INC. | $117.45 | 2025 | Tymlos |
| Gilead Sciences, INC. | $116.71 | 2024 | Livdelzi |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $112.66 | 2025 | Vascepa |
| Lucid Diagnostics INC. | $102.14 | 2022 | |
| Abbvie INC. | $99.67 | 2021 | |
| W. L. Gore & Associates, INC. | $91.98 | 2024 | Gore Viabahn Endoprosthesis With Heparin |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.16 | 2021 | |
| Novo Nordisk INC | $64.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Betsinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.